| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
82,378 |
76,286 |
$8.46M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
72,366 |
65,961 |
$6.85M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,772 |
8,019 |
$4.04M |
| J9271 |
Injection, pembrolizumab, 1 mg |
1,022 |
686 |
$3.04M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
7,006 |
6,786 |
$2.15M |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,948 |
9,867 |
$2.13M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,670 |
9,664 |
$1.81M |
| G0378 |
Hospital observation service, per hour |
16,193 |
7,203 |
$1.74M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
18,959 |
14,437 |
$1.62M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
28,287 |
20,297 |
$1.41M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16,488 |
12,212 |
$1.36M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
19,735 |
18,075 |
$1.32M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
49,340 |
44,063 |
$1.25M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,047 |
3,611 |
$1.25M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
1,027 |
1,021 |
$1.25M |
| 36902 |
|
3,200 |
2,804 |
$1.22M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,330 |
4,706 |
$1.21M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,642 |
24,431 |
$1.15M |
| J0897 |
Injection, denosumab, 1 mg |
1,744 |
1,490 |
$1.09M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,448 |
4,923 |
$1.04M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
28,663 |
23,840 |
$1.02M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,440 |
2,119 |
$968K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,559 |
1,353 |
$945K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
33,274 |
24,091 |
$897K |
| 80053 |
Comprehensive metabolic panel |
110,361 |
86,174 |
$819K |
| 71045 |
Radiologic examination, chest; single view |
23,963 |
19,359 |
$796K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
1,916 |
1,666 |
$788K |
| 71046 |
Radiologic examination, chest; 2 views |
19,622 |
17,918 |
$779K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
38,168 |
30,841 |
$770K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
10,508 |
5,209 |
$766K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,133 |
3,852 |
$744K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
126,062 |
95,373 |
$715K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,166 |
1,088 |
$704K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
5,984 |
4,364 |
$665K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,040 |
2,799 |
$644K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
924 |
853 |
$643K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,806 |
10,657 |
$609K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
1,604 |
984 |
$565K |
| S9123 |
Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used) |
10,446 |
1,819 |
$556K |
| 96367 |
|
7,699 |
3,847 |
$529K |
| 77412 |
|
6,369 |
618 |
$529K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
25,822 |
20,587 |
$485K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
19,925 |
6,985 |
$468K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
10,011 |
8,952 |
$446K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,898 |
2,689 |
$431K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,452 |
1,348 |
$399K |
| 96376 |
|
8,490 |
5,429 |
$390K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,489 |
1,350 |
$389K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
6,590 |
6,370 |
$382K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
4,218 |
4,015 |
$378K |
| D7140 |
Extraction, erupted tooth or exposed root |
1,358 |
1,132 |
$378K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,394 |
2,155 |
$369K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
11,203 |
9,724 |
$362K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,617 |
5,011 |
$362K |
| 36430 |
|
3,110 |
2,155 |
$346K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16,806 |
13,526 |
$345K |
| 77336 |
|
4,291 |
1,625 |
$333K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
3,903 |
984 |
$320K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,093 |
6,655 |
$316K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,247 |
1,159 |
$279K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
3,969 |
2,919 |
$275K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
8,615 |
5,283 |
$268K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
10,463 |
3,426 |
$252K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,614 |
3,332 |
$239K |
| 76801 |
|
1,720 |
1,525 |
$238K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
840 |
785 |
$235K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
22,213 |
6,626 |
$227K |
| 77334 |
|
1,321 |
877 |
$225K |
| 84443 |
Thyroid stimulating hormone (TSH) |
16,755 |
15,292 |
$223K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,550 |
1,383 |
$211K |
| 84484 |
|
22,674 |
17,584 |
$209K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,243 |
2,921 |
$208K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,710 |
7,077 |
$207K |
| 71250 |
|
2,977 |
2,648 |
$197K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
185 |
117 |
$192K |
| 95811 |
|
350 |
313 |
$192K |
| 96417 |
|
3,364 |
1,835 |
$189K |
| 93971 |
|
2,317 |
2,079 |
$188K |
| 96368 |
|
3,189 |
2,074 |
$187K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,922 |
1,789 |
$185K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,824 |
1,715 |
$177K |
| 74018 |
|
4,454 |
3,932 |
$175K |
| 93017 |
|
2,863 |
2,503 |
$169K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
28,733 |
21,905 |
$154K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,258 |
1,704 |
$151K |
| 83880 |
|
6,306 |
5,321 |
$148K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,594 |
8,135 |
$148K |
| 73221 |
|
865 |
799 |
$147K |
| 36907 |
|
622 |
537 |
$143K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
462 |
418 |
$137K |
| 77300 |
|
1,261 |
973 |
$137K |
| 73562 |
|
2,343 |
1,939 |
$132K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
11,707 |
3,893 |
$128K |
| G0151 |
Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes |
3,056 |
786 |
$123K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
456 |
432 |
$123K |
| 81025 |
|
19,089 |
17,225 |
$119K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,344 |
5,130 |
$116K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,445 |
1,746 |
$116K |
| 87430 |
|
10,904 |
10,537 |
$116K |
| 83735 |
|
26,599 |
18,360 |
$115K |
| 73030 |
|
2,184 |
1,911 |
$109K |
| 86901 |
|
11,445 |
9,490 |
$108K |
| 74022 |
|
1,681 |
1,563 |
$107K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,158 |
1,084 |
$106K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
57 |
39 |
$105K |
| 96415 |
|
2,120 |
1,223 |
$104K |
| 87070 |
|
13,185 |
12,528 |
$104K |
| 36905 |
|
417 |
294 |
$103K |
| 73630 |
|
1,760 |
1,556 |
$101K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,802 |
1,711 |
$100K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,347 |
5,133 |
$98K |
| D2934 |
|
422 |
352 |
$98K |
| Q5001 |
Hospice or home health care provided in patient's home/residence |
93 |
38 |
$97K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
567 |
488 |
$97K |
| D2330 |
|
369 |
359 |
$97K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,565 |
3,425 |
$96K |
| 82553 |
|
11,248 |
9,331 |
$95K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,353 |
2,033 |
$94K |
| 81001 |
|
37,401 |
32,848 |
$93K |
| 76641 |
|
1,725 |
1,424 |
$93K |
| 82948 |
|
28,062 |
17,296 |
$91K |
| 86850 |
|
9,219 |
7,753 |
$88K |
| 77295 |
|
149 |
118 |
$88K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
6,500 |
6,282 |
$86K |
| 77290 |
|
268 |
213 |
$86K |
| 76770 |
|
1,953 |
1,809 |
$85K |
| 73610 |
|
1,369 |
1,262 |
$84K |
| 85027 |
|
20,643 |
16,401 |
$83K |
| 93970 |
|
775 |
694 |
$82K |
| 83690 |
|
14,350 |
12,547 |
$81K |
| D2140 |
|
152 |
140 |
$80K |
| 36591 |
|
14,315 |
7,984 |
$80K |
| 72100 |
|
1,618 |
1,502 |
$78K |
| 76830 |
Ultrasound, transvaginal |
1,036 |
929 |
$78K |
| 73502 |
|
1,690 |
1,490 |
$76K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
19,205 |
14,769 |
$76K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,540 |
9,617 |
$76K |
| 80061 |
Lipid panel |
10,559 |
10,043 |
$75K |
| J1453 |
Injection, fosaprepitant, 1 mg |
971 |
475 |
$73K |
| 80320 |
|
4,281 |
3,821 |
$73K |
| 80329 |
|
1,577 |
1,438 |
$72K |
| 87040 |
|
5,765 |
5,113 |
$72K |
| 88312 |
|
2,896 |
2,696 |
$71K |
| 82728 |
|
7,821 |
7,022 |
$70K |
| 73130 |
|
1,268 |
1,069 |
$69K |
| 97162 |
|
3,419 |
3,045 |
$68K |
| 72141 |
|
430 |
380 |
$68K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
432 |
388 |
$67K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
937 |
860 |
$67K |
| J9035 |
Injection, bevacizumab, 10 mg |
69 |
24 |
$66K |
| D2335 |
|
166 |
165 |
$65K |
| 70486 |
|
333 |
307 |
$65K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
813 |
802 |
$64K |
| APT15 |
|
5,631 |
4,676 |
$63K |
| 88307 |
|
563 |
517 |
$63K |
| 82607 |
|
5,189 |
4,821 |
$60K |
| 83605 |
|
7,143 |
6,112 |
$60K |
| 82803 |
|
3,846 |
2,848 |
$58K |
| 88342 |
|
1,982 |
1,763 |
$57K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,371 |
393 |
$56K |
| 88341 |
|
774 |
702 |
$56K |
| 85610 |
|
21,330 |
15,919 |
$56K |
| 84466 |
|
6,526 |
5,934 |
$55K |
| 77427 |
|
682 |
338 |
$52K |
| 97163 |
|
3,306 |
2,777 |
$51K |
| 93880 |
|
627 |
561 |
$51K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,887 |
5,637 |
$50K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
33,452 |
26,972 |
$50K |
| 76536 |
|
1,009 |
914 |
$48K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
856 |
546 |
$48K |
| 84439 |
|
6,183 |
5,754 |
$48K |
| 85730 |
|
11,724 |
10,159 |
$46K |
| 72131 |
|
205 |
195 |
$45K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
2,257 |
2,096 |
$45K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
241 |
240 |
$44K |
| 82550 |
|
14,987 |
12,448 |
$44K |
| 86900 |
|
12,626 |
9,516 |
$43K |
| 93976 |
|
251 |
238 |
$42K |
| 73560 |
|
1,002 |
812 |
$41K |
| 84702 |
|
5,559 |
4,533 |
$41K |
| 73590 |
|
744 |
643 |
$41K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,459 |
1,311 |
$41K |
| 87400 |
|
4,369 |
2,147 |
$40K |
| 93356 |
|
1,164 |
1,067 |
$40K |
| D2150 |
Silver amalgam - two surfaces, primary or permanent |
135 |
117 |
$40K |
| 88304 |
|
1,563 |
1,473 |
$37K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
86 |
84 |
$35K |
| 82784 |
|
2,812 |
2,607 |
$35K |
| 92523 |
|
516 |
489 |
$35K |
| 70491 |
|
188 |
179 |
$34K |
| 77065 |
Tomosynthesis, mammo |
997 |
808 |
$34K |
| 76000 |
|
688 |
623 |
$34K |
| 76937 |
|
1,613 |
1,374 |
$33K |
| 86140 |
|
6,999 |
6,273 |
$33K |
| J1815 |
Injection, insulin, per 5 units |
5,372 |
2,831 |
$32K |
| 83520 |
|
1,803 |
1,501 |
$32K |
| 73110 |
|
623 |
530 |
$32K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,850 |
1,609 |
$32K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,073 |
956 |
$31K |
| 97597 |
|
838 |
523 |
$31K |
| 87428 |
|
898 |
856 |
$31K |
| 83540 |
|
6,882 |
6,265 |
$30K |
| G6002 |
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy |
2,953 |
516 |
$30K |
| 90791 |
Psychiatric diagnostic evaluation |
1,208 |
1,031 |
$30K |
| APT17 |
|
2,041 |
2,009 |
$30K |
| 97116 |
|
5,272 |
2,212 |
$30K |
| 86923 |
|
2,310 |
1,818 |
$30K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,016 |
1,702 |
$30K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,361 |
588 |
$29K |
| 87077 |
|
4,093 |
3,773 |
$29K |
| 77066 |
Tomosynthesis, mammo |
572 |
446 |
$29K |
| 76942 |
|
509 |
422 |
$29K |
| 87186 |
|
3,947 |
3,630 |
$29K |
| 95813 |
|
84 |
84 |
$29K |
| 95816 |
|
248 |
235 |
$29K |
| 82565 |
|
8,588 |
7,656 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,939 |
1,927 |
$29K |
| 96411 |
|
1,344 |
730 |
$28K |
| 76775 |
|
543 |
470 |
$28K |
| 77014 |
|
1,244 |
225 |
$28K |
| 85379 |
|
3,796 |
3,412 |
$28K |
| 43249 |
|
311 |
297 |
$28K |
| 84703 |
|
3,935 |
3,711 |
$27K |
| 72040 |
|
310 |
298 |
$27K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
608 |
578 |
$26K |
| 93458 |
|
27 |
25 |
$26K |
| 81003 |
|
14,962 |
13,611 |
$26K |
| 99201 |
|
1,221 |
1,065 |
$25K |
| 77280 |
|
152 |
123 |
$25K |
| 75710 |
|
81 |
62 |
$24K |
| 77001 |
|
403 |
336 |
$24K |
| 84153 |
|
2,137 |
1,903 |
$24K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
40,234 |
30,143 |
$24K |
| 73090 |
|
401 |
358 |
$24K |
| 72110 |
|
369 |
331 |
$24K |
| 82570 |
|
4,931 |
4,548 |
$23K |
| 72170 |
|
521 |
474 |
$23K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
326 |
296 |
$23K |
| 87807 |
|
2,236 |
2,173 |
$23K |
| 87899 |
|
1,830 |
1,493 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
23,836 |
18,236 |
$21K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
18,120 |
15,164 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
106,878 |
81,345 |
$21K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14,098 |
8,159 |
$21K |
| 80074 |
|
463 |
431 |
$20K |
| 82746 |
|
1,863 |
1,752 |
$19K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
2,536 |
2,247 |
$19K |
| 80076 |
|
4,238 |
3,771 |
$19K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
488 |
449 |
$19K |
| G0390 |
Trauma response team associated with hospital critical care service |
14 |
14 |
$18K |
| 86703 |
|
1,355 |
1,295 |
$18K |
| 86038 |
|
1,646 |
1,556 |
$18K |
| 74019 |
|
365 |
338 |
$18K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
127 |
111 |
$18K |
| 97032 |
|
2,925 |
1,181 |
$17K |
| 95886 |
|
145 |
143 |
$17K |
| 96402 |
|
525 |
474 |
$17K |
| 76642 |
|
465 |
399 |
$17K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19,246 |
16,042 |
$17K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
99 |
78 |
$17K |
| G0379 |
Direct admission of patient for hospital observation care |
717 |
668 |
$17K |
| 88112 |
|
723 |
634 |
$17K |
| 90715 |
|
784 |
701 |
$16K |
| 83970 |
|
465 |
407 |
$16K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
4,576 |
4,008 |
$16K |
| 84481 |
|
1,296 |
1,157 |
$16K |
| 85045 |
|
4,515 |
3,440 |
$15K |
| 76870 |
|
127 |
115 |
$15K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,888 |
3,026 |
$15K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,543 |
6,913 |
$15K |
| 83615 |
|
4,798 |
4,001 |
$15K |
| 86334 |
|
1,489 |
1,361 |
$15K |
| 77301 |
|
24 |
15 |
$15K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
8,319 |
5,246 |
$14K |
| 74220 |
|
295 |
264 |
$14K |
| 88142 |
|
692 |
667 |
$14K |
| APT16 |
|
1,002 |
949 |
$14K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,430 |
1,337 |
$13K |
| 85652 |
|
5,527 |
4,997 |
$13K |
| 96401 |
|
644 |
210 |
$13K |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
2,342 |
1,940 |
$13K |
| 84550 |
|
3,865 |
3,390 |
$13K |
| 92611 |
|
127 |
118 |
$12K |
| J2060 |
Injection, lorazepam, 2 mg |
2,564 |
1,916 |
$12K |
| 12001 |
|
136 |
135 |
$12K |
| 82378 |
|
1,296 |
1,034 |
$12K |
| L8000 |
Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type |
1,264 |
951 |
$11K |
| 83718 |
|
998 |
978 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,416 |
1,252 |
$11K |
| 36600 |
|
1,564 |
1,186 |
$11K |
| 95911 |
|
26 |
26 |
$11K |
| 74178 |
|
53 |
53 |
$11K |
| 84156 |
|
3,003 |
2,669 |
$11K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,324 |
4,672 |
$11K |
| 97014 |
|
1,050 |
366 |
$10K |
| 87210 |
|
2,479 |
2,359 |
$10K |
| J9190 |
Injection, fluorouracil, 500 mg |
1,497 |
548 |
$10K |
| 74230 |
|
128 |
119 |
$9K |
| Q3014 |
Telehealth originating site facility fee |
446 |
432 |
$9K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,844 |
3,321 |
$9K |
| 80361 |
|
356 |
353 |
$9K |
| 85520 |
|
988 |
859 |
$9K |
| 83883 |
|
849 |
780 |
$9K |
| 82043 |
|
1,965 |
1,865 |
$9K |
| 97166 |
|
817 |
716 |
$9K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,236 |
1,294 |
$9K |
| 80363 |
|
356 |
353 |
$9K |
| 97035 |
|
1,149 |
462 |
$9K |
| 83655 |
|
785 |
778 |
$8K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
299 |
212 |
$8K |
| 80346 |
|
358 |
354 |
$8K |
| 73552 |
|
167 |
150 |
$8K |
| 92588 |
|
112 |
108 |
$8K |
| 84450 |
|
2,345 |
2,042 |
$8K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,838 |
1,918 |
$8K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
67 |
67 |
$8K |
| 36589 |
|
82 |
68 |
$7K |
| 84145 |
|
947 |
795 |
$7K |
| 80358 |
|
357 |
354 |
$7K |
| 36561 |
|
20 |
13 |
$7K |
| 99215 |
Prolong outpt/office vis |
96 |
92 |
$7K |
| 29125 |
|
67 |
66 |
$7K |
| 77080 |
|
350 |
334 |
$7K |
| 96416 |
|
78 |
37 |
$7K |
| 92585 |
|
34 |
34 |
$7K |
| 83992 |
|
366 |
361 |
$7K |
| C1889 |
Implantable/insertable device, not otherwise classified |
359 |
337 |
$7K |
| 87205 |
|
3,368 |
3,033 |
$7K |
| 90837 |
Psychotherapy, 53 minutes with patient |
59 |
46 |
$6K |
| 86803 |
|
992 |
904 |
$6K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,365 |
545 |
$6K |
| 84166 |
|
786 |
695 |
$6K |
| 86235 |
|
83 |
80 |
$6K |
| 94644 |
|
548 |
480 |
$6K |
| 80369 |
|
245 |
243 |
$5K |
| 51702 |
|
184 |
158 |
$5K |
| 12011 |
|
57 |
53 |
$5K |
| 92587 |
|
116 |
109 |
$5K |
| 82248 |
|
1,212 |
971 |
$5K |
| 86480 |
|
80 |
78 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
21,323 |
16,578 |
$5K |
| 87147 |
|
1,197 |
1,122 |
$5K |
| 84100 |
|
4,139 |
2,568 |
$5K |
| 36593 |
|
43 |
24 |
$5K |
| 82274 |
|
373 |
329 |
$5K |
| J9045 |
Injection, carboplatin, 50 mg |
439 |
235 |
$5K |
| 80324 |
|
236 |
236 |
$5K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
2,858 |
2,133 |
$5K |
| 82140 |
|
743 |
478 |
$5K |
| 97161 |
|
395 |
361 |
$5K |
| J1953 |
Injection, levetiracetam, 10 mg |
557 |
346 |
$5K |
| 80353 |
|
357 |
354 |
$4K |
| 86160 |
|
262 |
253 |
$4K |
| 87806 |
|
214 |
202 |
$4K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
30 |
25 |
$4K |
| 87340 |
|
459 |
438 |
$4K |
| 90686 |
|
341 |
298 |
$4K |
| 71271 |
|
96 |
96 |
$4K |
| 12002 |
|
29 |
28 |
$4K |
| D2332 |
|
29 |
27 |
$4K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
48 |
41 |
$4K |
| 36558 |
|
17 |
12 |
$4K |
| J9171 |
Injection, docetaxel, 1 mg |
55 |
28 |
$4K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
47 |
37 |
$4K |
| J7510 |
Prednisolone oral, per 5 mg |
566 |
521 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
654 |
562 |
$3K |
| 95909 |
|
12 |
12 |
$3K |
| 92650 |
|
26 |
25 |
$3K |
| 86592 |
|
952 |
892 |
$3K |
| 83516 |
|
268 |
257 |
$3K |
| 84112 |
|
59 |
52 |
$3K |
| 99233 |
Prolong inpt eval add15 m |
82 |
30 |
$3K |
| 82785 |
|
178 |
164 |
$3K |
| 82247 |
|
745 |
600 |
$3K |
| 51701 |
|
78 |
70 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
10,014 |
4,699 |
$3K |
| 84520 |
|
1,743 |
1,533 |
$3K |
| 86902 |
|
318 |
229 |
$3K |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
575 |
499 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
97 |
91 |
$3K |
| 87075 |
|
402 |
360 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
17,217 |
7,116 |
$3K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,750 |
1,450 |
$3K |
| 85018 |
|
1,648 |
1,352 |
$3K |
| 62323 |
|
99 |
81 |
$3K |
| 84165 |
|
564 |
542 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
69 |
66 |
$3K |
| 80336 |
|
120 |
116 |
$3K |
| J3480 |
Injection, potassium chloride, per 2 meq |
3,715 |
2,148 |
$3K |
| 80370 |
|
120 |
116 |
$3K |
| 80164 |
|
251 |
212 |
$3K |
| 92567 |
|
143 |
135 |
$3K |
| 82747 |
|
241 |
211 |
$3K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
420 |
362 |
$3K |
| 74160 |
|
35 |
29 |
$3K |
| 93225 |
|
30 |
27 |
$2K |
| 93226 |
|
32 |
30 |
$2K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
932 |
426 |
$2K |
| 85014 |
|
1,994 |
1,607 |
$2K |
| 82009 |
|
893 |
761 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
3,749 |
3,104 |
$2K |
| 82731 |
|
32 |
29 |
$2K |
| 88720 |
|
593 |
501 |
$2K |
| 43235 |
|
15 |
14 |
$2K |
| 31500 |
|
24 |
17 |
$2K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,477 |
1,794 |
$2K |
| 80325 |
|
117 |
114 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
446 |
382 |
$2K |
| 77003 |
|
15 |
15 |
$2K |
| 86300 |
|
150 |
131 |
$2K |
| 97802 |
|
59 |
57 |
$2K |
| 80342 |
|
120 |
116 |
$2K |
| 77338 |
|
29 |
15 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
314 |
257 |
$2K |
| 64415 |
|
223 |
189 |
$2K |
| 70496 |
|
13 |
13 |
$2K |
| 87102 |
|
276 |
239 |
$2K |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
1,368 |
1,128 |
$2K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
460 |
220 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
12 |
12 |
$2K |
| 77417 |
|
54 |
27 |
$2K |
| 85660 |
|
315 |
261 |
$2K |
| 90834 |
Psychotherapy, 45 minutes with patient |
21 |
16 |
$2K |
| J3360 |
Injection, diazepam, up to 5 mg |
425 |
372 |
$2K |
| 86317 |
|
15 |
15 |
$1K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
76 |
25 |
$1K |
| 73060 |
|
26 |
24 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
94 |
92 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,884 |
2,610 |
$1K |
| 77387 |
|
844 |
94 |
$1K |
| 36416 |
|
3,150 |
1,753 |
$1K |
| 71101 |
|
13 |
13 |
$1K |
| 82465 |
|
400 |
387 |
$1K |
| 82330 |
|
167 |
144 |
$1K |
| 94002 |
|
19 |
16 |
$1K |
| 92950 |
|
21 |
13 |
$1K |
| 94729 |
|
40 |
40 |
$1K |
| 0399T |
|
158 |
139 |
$1K |
| 29581 |
|
63 |
39 |
$1K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
281 |
266 |
$1K |
| J9267 |
Injection, paclitaxel, 1 mg |
87 |
38 |
$1K |
| 36215 |
|
15 |
12 |
$1K |
| 87420 |
|
165 |
164 |
$1K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
199 |
88 |
$1K |
| 94726 |
|
27 |
27 |
$1K |
| 86376 |
|
69 |
69 |
$1K |
| 85384 |
|
143 |
120 |
$1K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
231 |
124 |
$1K |
| 36901 |
|
14 |
13 |
$1K |
| 84460 |
|
844 |
787 |
$1K |
| 84132 |
|
800 |
656 |
$1K |
| 86225 |
|
78 |
76 |
$998.48 |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
12 |
12 |
$981.55 |
| 86200 |
|
80 |
78 |
$980.62 |
| 80356 |
|
351 |
349 |
$969.88 |
| 82040 |
|
713 |
646 |
$955.22 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
348 |
149 |
$920.57 |
| 82533 |
|
72 |
68 |
$913.77 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
47 |
46 |
$908.97 |
| 94060 |
|
12 |
12 |
$870.16 |
| 73100 |
|
16 |
12 |
$867.84 |
| 87081 |
|
175 |
165 |
$864.28 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
30 |
30 |
$859.66 |
| 87206 |
|
189 |
159 |
$851.23 |
| 82951 |
|
52 |
51 |
$849.19 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,465 |
1,115 |
$843.92 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,256 |
1,304 |
$843.80 |
| 80069 |
|
273 |
119 |
$840.25 |
| C1819 |
Surgical tissue localization and excision device (implantable) |
212 |
205 |
$835.62 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
445 |
408 |
$832.73 |
| 17250 |
|
90 |
62 |
$818.91 |
| 84155 |
|
1,007 |
895 |
$810.19 |
| 86762 |
|
43 |
42 |
$803.55 |
| 83021 |
|
138 |
134 |
$796.06 |
| 77263 |
|
14 |
12 |
$780.67 |
| 43450 |
|
15 |
13 |
$755.68 |
| APT18 |
|
53 |
50 |
$730.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
33 |
32 |
$714.45 |
| 73070 |
|
14 |
13 |
$694.58 |
| 87015 |
|
182 |
146 |
$687.85 |
| APT14 |
|
60 |
52 |
$686.34 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
24 |
12 |
$667.06 |
| 97033 |
|
64 |
27 |
$648.33 |
| 29515 |
|
14 |
13 |
$642.11 |
| 86920 |
|
86 |
68 |
$633.23 |
| 92526 |
|
94 |
26 |
$619.84 |
| 80354 |
|
352 |
350 |
$579.30 |
| 80373 |
|
347 |
344 |
$559.33 |
| 80348 |
|
350 |
348 |
$535.34 |
| 82164 |
|
41 |
41 |
$518.97 |
| J0595 |
Injection, butorphanol tartrate, 1 mg |
108 |
93 |
$514.82 |
| 80365 |
|
350 |
348 |
$514.43 |
| 86704 |
|
39 |
39 |
$511.83 |
| 80368 |
|
112 |
110 |
$503.16 |
| 86706 |
|
60 |
52 |
$502.23 |
| 80349 |
|
350 |
348 |
$496.53 |
| 97016 |
|
53 |
12 |
$488.54 |
| APT02 |
|
71 |
66 |
$468.61 |
| 43760 |
|
12 |
12 |
$466.36 |
| 97167 |
|
32 |
29 |
$466.27 |
| 80355 |
|
347 |
345 |
$457.22 |
| 80366 |
|
346 |
344 |
$454.90 |
| 80359 |
|
353 |
351 |
$445.73 |
| 87046 |
|
62 |
56 |
$440.02 |
| 80372 |
|
346 |
344 |
$429.71 |
| 80367 |
|
347 |
345 |
$429.71 |
| 86696 |
|
13 |
12 |
$398.00 |
| 87045 |
|
50 |
44 |
$395.54 |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
28 |
25 |
$391.90 |
| 82232 |
|
30 |
30 |
$390.59 |
| 86255 |
|
29 |
28 |
$379.31 |
| 80202 |
|
57 |
24 |
$377.43 |
| 76998 |
|
18 |
16 |
$360.28 |
| 81002 |
|
170 |
157 |
$357.05 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
129 |
113 |
$354.42 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
55 |
43 |
$349.48 |
| J1630 |
Injection, haloperidol, up to 5 mg |
522 |
427 |
$343.06 |
| 93922 |
|
13 |
13 |
$339.74 |
| APT09 |
|
43 |
26 |
$321.57 |
| 96523 |
|
91 |
78 |
$317.09 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
98 |
83 |
$315.83 |
| 84403 |
|
13 |
13 |
$315.16 |
| 0011A |
|
43 |
37 |
$287.30 |
| 94200 |
|
25 |
25 |
$283.15 |
| 82977 |
|
117 |
107 |
$272.65 |
| 86695 |
|
13 |
12 |
$268.13 |
| 86708 |
|
25 |
25 |
$263.93 |
| 87209 |
|
13 |
13 |
$262.21 |
| 82310 |
|
62 |
50 |
$249.75 |
| 0012A |
|
14 |
13 |
$248.01 |
| J1790 |
Injection, droperidol, up to 5 mg |
113 |
104 |
$243.14 |
| 51798 |
|
25 |
25 |
$237.10 |
| 80360 |
|
114 |
112 |
$234.92 |
| 80357 |
|
113 |
111 |
$234.92 |
| 80333 |
|
112 |
110 |
$234.92 |
| 86705 |
|
29 |
27 |
$231.59 |
| 87653 |
|
13 |
12 |
$222.18 |
| 86922 |
|
38 |
26 |
$208.46 |
| 82952 |
|
51 |
51 |
$171.74 |
| 82947 |
|
87 |
62 |
$162.66 |
| 76001 |
|
83 |
71 |
$154.01 |
| 86039 |
|
19 |
14 |
$151.15 |
| 80185 |
|
12 |
12 |
$142.75 |
| 87177 |
|
13 |
13 |
$129.82 |
| 86921 |
|
38 |
26 |
$128.34 |
| 87449 |
|
13 |
12 |
$127.12 |
| 82955 |
|
12 |
12 |
$115.21 |
| 82105 |
|
14 |
12 |
$111.05 |
| 86880 |
|
25 |
25 |
$110.72 |
| 84436 |
|
31 |
25 |
$109.81 |
| 86870 |
|
25 |
25 |
$104.94 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
21 |
12 |
$103.06 |
| 85651 |
|
23 |
22 |
$102.21 |
| 87324 |
|
14 |
13 |
$96.81 |
| 82150 |
|
13 |
12 |
$94.96 |
| 80177 |
|
13 |
12 |
$77.19 |
| 84295 |
|
94 |
79 |
$75.31 |
| 86304 |
|
15 |
12 |
$69.39 |
| 83010 |
|
33 |
29 |
$67.71 |
| J3411 |
Injection, thiamine hcl, 100 mg |
30 |
25 |
$63.94 |
| J1956 |
Injection, levofloxacin, 250 mg |
34 |
26 |
$62.82 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
21 |
18 |
$62.62 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
61 |
40 |
$59.46 |
| 83986 |
|
19 |
17 |
$53.80 |
| 82272 |
|
13 |
12 |
$43.46 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
12 |
12 |
$41.15 |
| 89055 |
|
16 |
16 |
$36.16 |
| 82542 |
|
12 |
12 |
$34.89 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
74 |
62 |
$30.21 |
| 96377 |
|
19 |
12 |
$29.50 |
| 99406 |
|
22 |
16 |
$26.52 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
32 |
25 |
$18.19 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
3,273 |
2,895 |
$17.52 |
| J0456 |
Injection, azithromycin, 500 mg |
15 |
14 |
$14.55 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
234 |
177 |
$5.89 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
53 |
50 |
$5.42 |
| A4649 |
Surgical supply; miscellaneous |
928 |
830 |
$2.24 |
| A9270 |
Non-covered item or service |
12,832 |
7,269 |
$1.76 |
| A9150 |
Non-prescription drugs |
12 |
12 |
$0.30 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
46 |
36 |
$0.11 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
818 |
718 |
$0.02 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
855 |
744 |
$0.02 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
73 |
62 |
$0.01 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
207 |
170 |
$0.01 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
204 |
167 |
$0.01 |
| C1757 |
Catheter, thrombectomy/embolectomy |
1,395 |
1,070 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
950 |
745 |
$0.00 |
| 80338 |
|
112 |
110 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
12 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
15 |
12 |
$0.00 |
| C1874 |
Stent, coated/covered, with delivery system |
48 |
38 |
$0.00 |
| 90662 |
|
17 |
14 |
$0.00 |
| 99053 |
|
73 |
71 |
$0.00 |
| 99442 |
|
17 |
15 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
121 |
112 |
$0.00 |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
401 |
261 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
56 |
24 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
89 |
86 |
$0.00 |
| C1769 |
Guide wire |
3,600 |
3,189 |
$0.00 |
| A4215 |
Needle, sterile, any size, each |
797 |
716 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
3,784 |
3,286 |
$0.00 |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
31 |
15 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
48 |
39 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
51 |
50 |
$0.00 |
| 90654 |
|
21 |
16 |
$0.00 |
| 74174 |
|
15 |
13 |
$0.00 |
| A6213 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
15 |
14 |
$0.00 |